Related Experiment Video
Updated: Feb 26, 2026
The Pilocarpine Model of Temporal Lobe Epilepsy and EEG Monitoring Using Radiotelemetry System in Mice
Published on: February 27, 2018
The effect of CXCR2 inhibition on seizure activity in the pilocarpine epilepsy mouse model
Tao Xu1, Xinyuan Yu1, Teng Wang1
1Department of Neurology, The Second Affiliated Hospital of Chongqing Medical University, 76 Linjiang Road, Yuzhong District, Chongqing 400010, China.
Abstract:
C-X-C motif chemokine receptor 2 (CXCR2) is one of the most well characterized chemokine receptors and is a potential target for treating brain pathologies involving inflammatory processes, including epilepsy. However, the role of CXCR2 in epilepsy has not been investigated, and whether CXCR2 modulates seizure activity in temporal lobe epilepsy (TLE) remains unknown. In this study, we aimed to determine the potential role of CXCR2 in intractable TLE patients and in pilocarpine-induced epileptic mice. Here, through Western blotting and semi-quantitative immunohistochemistry, we detected that CXCR2 protein expression was up-regulated (by nearly 50%) in the temporal neocortex of TLE patients and in the hippocampus and adjacent temporal cortex of pilocarpine mice model. Double-label immunofluorescence and immunohistochemical analysis indicated that CXCR2 was expressed in neurons. To investigate the effect of the CXCR2 selective antagonist SB225002 on seizure activity, SB225002 was i.p. administered during the latency window of spontaneous recurrent seizures (SRSs). This treatment increased (by nearly 40%) the latency of SRSs and reduced (by nearly 50%) the frequency of SRSs during the chronic period of epilepsy. This study suggests that CXCR2 plays a critical role in modifying epileptic seizure activity and that CXCR2 blockade could be a potential molecular therapeutic target for epilepsy.
Insights
C-X-C motif chemokine receptor 2 (CXCR2) is upregulated in epilepsy. Blocking CXCR2 in mice increased seizure latency and reduced seizure frequency, suggesting CXCR2 as a therapeutic target for epilepsy.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- C-X-C motif chemokine receptor 2 (CXCR2) is a well-characterized chemokine receptor implicated in inflammatory processes.
- Its role in epilepsy and modulation of seizure activity in temporal lobe epilepsy (TLE) remains largely unexplored.
Purpose of the Study:
- To investigate the role of CXCR2 in intractable TLE patients and a pilocarpine-induced epilepsy mouse model.
- To determine if CXCR2 blockade affects seizure activity.
Main Methods:
- Western blotting and immunohistochemistry to assess CXCR2 protein expression in TLE patients and epileptic mice.
- Immunofluorescence to identify CXCR2-expressing cells.
- Administration of the CXCR2 antagonist SB225002 to pilocarpine-induced epileptic mice to evaluate effects on spontaneous recurrent seizures (SRSs).
Main Results:
- CXCR2 protein expression was significantly upregulated in the temporal neocortex of TLE patients and in the hippocampus and temporal cortex of pilocarpine mice.
- CXCR2 was found to be expressed in neurons.
- Administration of SB225002 increased SRS latency by approximately 40% and reduced SRS frequency by approximately 50% in the chronic epilepsy phase.
Conclusions:
- CXCR2 plays a critical role in modulating epileptic seizure activity.
- CXCR2 blockade represents a potential molecular therapeutic strategy for epilepsy.
